These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


280 related items for PubMed ID: 16870951

  • 1. The effect of alpha-adrenergic antagonists in chronic prostatitis/chronic pelvic pain syndrome: a meta-analysis of randomized controlled trials.
    Yang G, Wei Q, Li H, Yang Y, Zhang S, Dong Q.
    J Androl; 2006; 27(6):847-52. PubMed ID: 16870951
    [Abstract] [Full Text] [Related]

  • 2. Role of alpha1-blockers in chronic prostatitis syndromes.
    Nickel JC.
    BJU Int; 2008 Mar; 101 Suppl 3():11-6. PubMed ID: 18307680
    [Abstract] [Full Text] [Related]

  • 3. Pharmacotherapy strategies in chronic prostatitis/chronic pelvic pain syndrome management.
    Murphy AB, Nadler RB.
    Expert Opin Pharmacother; 2010 Jun; 11(8):1255-61. PubMed ID: 20429665
    [Abstract] [Full Text] [Related]

  • 4. Terazosin therapy for chronic prostatitis/chronic pelvic pain syndrome: a randomized, placebo controlled trial.
    Cheah PY, Liong ML, Yuen KH, Teh CL, Khor T, Yang JR, Yap HW, Krieger JN.
    J Urol; 2003 Feb; 169(2):592-6. PubMed ID: 12544314
    [Abstract] [Full Text] [Related]

  • 5. Treatment of chronic prostatitis/chronic pelvic pain syndrome with tamsulosin: a randomized double blind trial.
    Nickel JC, Narayan P, McKay J, Doyle C.
    J Urol; 2004 Apr; 171(4):1594-7. PubMed ID: 15017228
    [Abstract] [Full Text] [Related]

  • 6. Phenotypically directed multimodal therapy for chronic prostatitis/chronic pelvic pain syndrome: a prospective study using UPOINT.
    Shoskes DA, Nickel JC, Kattan MW.
    Urology; 2010 Jun; 75(6):1249-53. PubMed ID: 20363491
    [Abstract] [Full Text] [Related]

  • 7. Failure of a monotherapy strategy for difficult chronic prostatitis/chronic pelvic pain syndrome.
    Nickel JC, Downey J, Ardern D, Clark J, Nickel K.
    J Urol; 2004 Aug; 172(2):551-4. PubMed ID: 15247727
    [Abstract] [Full Text] [Related]

  • 8. More effects of extracorporeal magnetic innervation and terazosin therapy than terazosin therapy alone for non-inflammatory chronic pelvic pain syndrome: a pilot study.
    Paick JS, Lee SC, Ku JH.
    Prostate Cancer Prostatic Dis; 2006 Aug; 9(3):261-5. PubMed ID: 16683008
    [Abstract] [Full Text] [Related]

  • 9. [Combined therapy for the chronic pelvic pain syndrome].
    Xu S, Qi G, Tang P, Li Y.
    Zhonghua Nan Ke Xue; 2004 Jun; 10(6):429-30, 433. PubMed ID: 15267206
    [Abstract] [Full Text] [Related]

  • 10. Fluoxetine ameliorates symptoms of refractory chronic prostatitis/chronic pelvic pain syndrome.
    Xia D, Wang P, Chen J, Wang S, Jiang H.
    Chin Med J (Engl); 2011 Jul; 124(14):2158-61. PubMed ID: 21933619
    [Abstract] [Full Text] [Related]

  • 11. α-blockers, antibiotics and anti-inflammatories have a role in the management of chronic prostatitis/chronic pelvic pain syndrome.
    Thakkinstian A, Attia J, Anothaisintawee T, Nickel JC.
    BJU Int; 2012 Oct; 110(7):1014-22. PubMed ID: 22471591
    [Abstract] [Full Text] [Related]

  • 12. A placebo-controlled comparison of the efficiency of triple- and monotherapy in category III B chronic pelvic pain syndrome (CPPS).
    Tuğcu V, Taşçi AI, Fazlioğlu A, Gürbüz G, Ozbek E, Sahin S, Kurtuluş F, Cek M.
    Eur Urol; 2007 Apr; 51(4):1113-7; discussion 1118. PubMed ID: 17084960
    [Abstract] [Full Text] [Related]

  • 13. Identification, pharmacologic considerations, and management of prostatitis.
    Schiller DS, Parikh A.
    Am J Geriatr Pharmacother; 2011 Feb; 9(1):37-48. PubMed ID: 21459307
    [Abstract] [Full Text] [Related]

  • 14. Two-year experience with the german-translated version of the NIH-CPSI in patients with CP/CPPS.
    Schneider H, Brähler E, Ludwig M, Hochreiter W, Collins MF, Eremenco S, Weidner W.
    Urology; 2004 Jun; 63(6):1027-30. PubMed ID: 15183940
    [Abstract] [Full Text] [Related]

  • 15. Chronic prostatitis/chronic pelvic pain syndrome: symptoms are aggravated by cold and become less distressing with age and time.
    Hedelin H, Jonsson K.
    Scand J Urol Nephrol; 2007 Jun; 41(6):516-20. PubMed ID: 17853027
    [Abstract] [Full Text] [Related]

  • 16. [Preliminary experience in treatment of chronic prostatitis/chronic pelvic pain syndrome with Longjintonglin capsule].
    Shang XJ, Huang YF, Shao Y, Xue XT, Guan FG, Li G, Wang J.
    Zhonghua Nan Ke Xue; 2006 Apr; 12(4):371-3. PubMed ID: 16683576
    [Abstract] [Full Text] [Related]

  • 17. [Retrospective analysis of the combined therapy of terazosin with chlormezanone for chronic prostatitis/chronic pelvic pain syndrome].
    Yan S, Li HZ, Zhang XY, Li HJ.
    Zhonghua Nan Ke Xue; 2009 Aug; 15(8):717-20. PubMed ID: 19852273
    [Abstract] [Full Text] [Related]

  • 18. A prospective, randomized, double-blind trial to evaluate the role of a short reducing course of oral corticosteroid therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome.
    Bates SM, Hill VA, Anderson JB, Chapple CR, Spence R, Ryan C, Talbot MD.
    BJU Int; 2007 Feb; 99(2):355-9. PubMed ID: 17313424
    [Abstract] [Full Text] [Related]

  • 19. Comparative analysis of efficacy of different combination therapies of α-receptor blockers and traditional Chinese medicine external therapy in the treatment of chronic prostatitis/chronic pelvic pain syndrome: Bayesian network meta-analysis.
    Zhang K, Zhang Y, Hong S, Cao Y, Liu C.
    PLoS One; 2023 Feb; 18(4):e0280821. PubMed ID: 37079509
    [Abstract] [Full Text] [Related]

  • 20. [Effects of alpha1 adrenoceptor antagonist, naftopidil, on non-bacterial chronic pelvic pain syndrome in patients with lower urinary tract syndrome: evaluation of its efficacy using NIH-CPSI after 4-week treatment].
    Suzuki A, Ohinata M, Fujishima M, Hirano S, Kudou T, Funaki H, Akasaka T.
    Hinyokika Kiyo; 2010 Apr; 56(4):215-9. PubMed ID: 20448445
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 14.